Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation

Background: Homocysteine metabolism may be impaired in chronic liver disease, possibly contributing to fibrogenesis and disease complications. Objective: The goal was to investigate the prevalence and determinants of basal and postprandial hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation (OLT). Design: This was a cross-sectional study of 323 patients with chronic liver disease (93 with hepatitis, 8 with fatty liver, 168 with cirrhosis, and 54 after OLT) and 25 healthy control subjects. Portohepatovenous gradients of total homocysteine (tHcy) and methionine and postload methionine and tHcy kinetics before and after 10 d of supplementation with folate plus vitamin B-6 were investigated in subgroups. Results: Basal hyperhomocysteinemia was observed in all patient groups (34% of patients with hepatitis, 50% with fatty liver, 54% with cirrhosis, and 52% after OLT). It was more frequently seen in patients with elevated plasma creatinine concentrations and at advanced stages of liver disease. Mean plasma folate was normal in patients with liver disease, but vitamin B-12 was elevated in cirrhosis and vitamin B-6 was low after OLT. There were significant negative associations between tHcy and folic acid or vitamin B-12 concentrations in control subjects and in patients with hepatitis and after OLT. No systematic association between portohepatovenous differences in tHcy and methionine concentrations was found. Cirrhosis was accompanied by impaired methionine clearance. After vitamin supplementation, the area under the tHcy curve improved in cirrhosis at nearly unchanged basal tHcy concentrations. Conclusions: Basal hyperhomocysteinemia is seen in 50% of patients with cirrhosis and after OLT. Basal tHcy concentrations do not change significantly after supplementation with folate and vitamin B-6, but postprandial Hcy metabolism improves. Am J Clin Nutr 2003;77:1269–77.

[1]  C. Loinaz,et al.  Determinants of increased plasma homocysteine in 221 stable liver transplant patients. , 2001, Clinical chemistry.

[2]  F. Corrales,et al.  Hyperhomocysteinemia in Liver Cirrhosis: Mechanisms and Role in Vascular and Hepatic Fibrosis , 2001, Hypertension.

[3]  Y. Baruch,et al.  Basal and Post-Methionine Serum Homocysteine and Lipoprotein Abnormalities in Patients With Chronic Liver Disease , 2001, Journal of Investigative Medicine.

[4]  A. Bosy-Westphal,et al.  Increased plasma homocysteine in liver cirrhosis. , 2001, Hepatology research : the official journal of the Japan Society of Hepatology.

[5]  E. Rimm,et al.  Association of folate intake and serum homocysteine in elderly persons according to vitamin supplementation and alcohol use. , 2001, The American journal of clinical nutrition.

[6]  Shelly C. Lu,et al.  Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. , 2000, Journal of hepatology.

[7]  B. Sangro,et al.  Hyperhomocysteinemia in liver transplant recipients: Prevalence and multivariate analysis of predisposing factors , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[8]  J. Rockstroh,et al.  Is the increase in serum cystathionine levels in patients with liver cirrhosis a consequence of impaired homocysteine transsulfuration at the level of gamma-cystathionase? , 2000, Scandinavian journal of gastroenterology.

[9]  M. Cravo,et al.  Hyperhomocysteinemia in chronic alcoholism: relations to folic acid and vitamins B(6) and B(12) status. , 2000, Nutrition.

[10]  M. Ávila,et al.  Induction of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: a new role for homocysteine in liver fibrosis. , 1999, Biochimica et biophysica acta.

[11]  C. Leevy,et al.  Cobalamin (vitamin B12) and holotranscobalamin changes in plasma and liver tissue in alcoholics with liver disease. , 1998, Journal of the American College of Nutrition.

[12]  A. Hettinger,et al.  Time course of total cysteine, glutathione and homocysteine in plasma of patients with chronic hepatitis C treated with interferon-alpha with and without supplementation with N-acetylcysteine. , 1998, Journal of hepatology.

[13]  J. Cutler,et al.  Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[14]  I. Rosenberg,et al.  Abnormal homocysteine metabolism in rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[15]  M. Plauth,et al.  ESPEN guidelines for nutrition in liver disease and transplantation. , 1997, Clinical nutrition.

[16]  I. Rosenberg,et al.  Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus , 1996, The Lancet.

[17]  J. Loscalzo.  The oxidant stress of hyperhomocyst(e)inemia. , 1996, The Journal of clinical investigation.

[18]  P. Nilsson-ehle,et al.  The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. , 1996, Scandinavian journal of clinical and laboratory investigation.

[19]  B. Norrving,et al.  Plasma homocysteine in the acute and convalescent phases after stroke. , 1995, Stroke.

[20]  O. Selberg,et al.  Metabolism of energy-yielding substrates in patients with liver cirrhosis , 1994, The clinical investigator.

[21]  A. von Eckardstein,et al.  Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[22]  M. Berglund,et al.  Elevated plasma homocysteine in alcoholics. , 1993, Alcoholism, clinical and experimental research.

[23]  M. Zoli,et al.  Defective methionine metabolism in cirrhosis: Relation to severity of liver disease , 1992, Hepatology.

[24]  R. Paroni,et al.  High-performance liquid chromatographic method with fluorescence detection for the determination of total homocyst(e)ine in plasma. , 1992, Journal of chromatography.

[25]  P. Ueland,et al.  Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate. , 1991, Cancer research.

[26]  P. Ueland,et al.  Fasting plasma homocysteine as a sensitive parameter of antifolate effect: A study of psoriasis patients receiving low‐dose methotrexate treatment , 1989, Clinical pharmacology and therapeutics.

[27]  W. Millikan,et al.  Activities of the hepatic enzymes of vitamin B6 metabolism for patients with cirrhosis. , 1986, The American journal of clinical nutrition.

[28]  M. Kutner,et al.  The fasting B6 vitamer profile and response to a pyridoxine load in normal and cirrhotic subjects , 1986, Hepatology.

[29]  J. Boitnott,et al.  Relationship between pyridoxal 5'-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. , 1984, Gastroenterology.

[30]  I. Chanarin.  The effects of nitrous oxide on cobalamins, folates, and on related events. , 1982, Critical reviews in toxicology.

[31]  B. Anderson,et al.  Hydrolysis of pyridoxal-5'-phosphate in plasma in conditions with raised alkaline phosphate. , 1980, Gut.

[32]  S. Schenker,et al.  Abnormal regulation of plasma pyridoxal 5'-phosphate in patients with liver disease. , 1976, Gastroenterology.

[33]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[34]  P. Gérard,et al.  Alcoholic cirrhosis and cobalamin metabolism. , 1997, Digestion.

[35]  J. Mato,et al.  S‐adenosyl‐L‐methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis , 1988, Hepatology.

[36]  G. Shaw,et al.  Blood vitamin status (B1, B2, B6, folic acid and B12) in patients with alcoholic liver disease. , 1982, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[37]  S. Heymsfield,et al.  Evidence for impairment of transsulfuration pathway in cirrhosis. , 1981, Gastroenterology.